Dynamics of Organ Damage and Immune Exhaustion During Sepsis
Part of paid clinical trials in Rochester, Minnesota.
- Sponsor
- Mayo Clinic
- Study ID
- NCT06817408
- Status
- Recruiting
Conditions
- Sepsis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Observation — OTHEROne additional blood draw in the Emergency Department as part of their standard of care visit.
Study Details
This is a prospective, non-randomized study investigating if organ damage and immune changes can be measured by liquid biopsy NGS through advanced analytical methods.
Key Dates
- Start date
- Mar 25, 2025
- Status verified
- Mar 2026
- Primary completion
- Jul 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 1,000 participants (estimated)
Primary Outcome Measure
Patient Survival [ Time Frame: From date of patient enrollment until date of death for any cause or up to 1 year after patient enrollment date, whichever comes first. ]
Central Contacts
- Derek E Vanmeter507-255-4732
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic Rochester | Rochester | Minnesota | 55905 | Aadel A Chaudhuri, M.D., Ph.D. (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Rochester, MN
By research site
Related Studies
- Senolytics To slOw Progression of Sepsis (STOP-Sepsis) TrialPHASE2 · Recruiting · University of Minnesota · Gainesville, Florida
- MID-STEP (MIDodrine for Sepsis Treatment and Early vasoPressor Weaning) TrialPHASE2 · Recruiting · Mayo Clinic · Scottsdale, Arizona
- Assessing Immune Dysfunction in SepsisRecruiting · University of Minnesota · Minneapolis, Minnesota
- BLOOM: Pragmatic Feasibility TrialRecruiting · Mayo Clinic · Rochester, Minnesota